Vineet Laboratories (BOM:543298) Cash And Cash Equivalents : ₹0 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Vineet Laboratories Cash And Cash Equivalents?

Vineet Laboratories's quarterly cash and cash equivalents declined from Jun. 2023 (₹6.81 Mil) to Sep. 2023 (₹6.21 Mil) but then stayed the same from Sep. 2023 (₹6.21 Mil) to Dec. 2023 (₹0.00 Mil).

Vineet Laboratories's annual cash and cash equivalents increased from Mar. 2021 (₹7.51 Mil) to Mar. 2022 (₹166.59 Mil) but then declined from Mar. 2022 (₹166.59 Mil) to Mar. 2023 (₹6.31 Mil).

Vineet Laboratories Cash And Cash Equivalents Historical Data

The historical data trend for Vineet Laboratories's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vineet Laboratories Cash And Cash Equivalents Chart

Vineet Laboratories Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.07

0.04

7.51

166.59

6.31

Vineet Laboratories Quarterly Data
	Mar17	Mar18	Mar19	Mar20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash And Cash Equivalents	Get a 7-Day Free Trial											9.11	6.31	6.81	6.21	-

Vineet Laboratories Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Vineet Laboratories (BOM:543298) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Vineet Laboratories Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Vineet Laboratories's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Vineet Laboratories (BOM:543298) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Vineet Laboratories Ltd (BOM:543298) » Definitions » Cash And Cash Equivalents

Traded in Other Exchanges

VINEETLAB:India

Address

5-5-160, Malleswari Nilayam, Opposite Vishnu Theatre, Chintalakunta, L.B.Nagar, Hyderabad, TG, IND, 500 074

Website

https://www.vineetlabs.co.in

Vineet Laboratories Ltd Formerly known as Ortin Laboratories Limited, Unit-II is engaged in the business of Pharmaceutical intermediates and Fine chemicals. The products of the companies include Dimethyl phenoxy acetyl chloride, Dimethyl Phenoxy Acetic Acid, Isopropyl-beta-D-thiogalactopyranoside and Nitrophenyl phosphate disodium salt among others. Geographically, the company operates within India and outside India, with a majority of revenue coming from India. The company has one business segment, manufacture of Drug Intermediates & Bulk Dugs.

Vineet Laboratories (BOM:543298) Headlines

No Headlines